The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO 2023 | BRAF testing in CRC: comprehensive approach across all stages, affordability, and global advocacy
Julien Taieb, MD, PhD, Paris Descartes University in Paris, France, advocates for comprehensive BRAF testing in all stages of colorectal cancer, not just in metastatic disease. Highlighting the dual role of providing both prognostic and therapeutic guidance, Dr. Taieb emphasizes the increasing affordability of these tests. He asserts the importance of widespread testing worldwide, across various disease stages, considering the accessibility and relatively low cost of the procedure. This recommendation aims to enhance the understanding and management of colorectal cancer at all stages. The interview occurred at the European Society for Medical Oncology (ESMO) 2023 Congress in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP), protected by copyright laws and treaties around the world. All rights are reserved.
